Long-term follow-up study for gene therapy in critical limb ischemia
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This study follows up with people who previously took part in a clinical trial testing an experimental gene therapy for critical limb ischemia (severe leg pain or sores due to blocked arteries). It aims to see how well the treatment works over time. If you were in that earlier trial and received at least one dose, joining this follow-up could help researchers learn more about the therapy's lasting effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in a late-stage (Phase III) trial of the gene therapy treatment called Donaperminogene Seltoplasmid (or NL003) for critical limb ischemia.
- You received at least one dose of the study treatment during that earlier trial.
- You are willing to sign a consent form agreeing to participate.
- You agree to share your medical information and let the researchers collect past or future health data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of absorbable scaffold (like a temporary mesh) that is placed inside a blocked artery below the knee to restore blood flow. It is for people with severe leg pain or small ulcers due to chronic limb-threatening ischemia (CLI) who have a short blockage in a specific artery.
This study looks at results of a minimally invasive procedure done inside blood vessels (endovascular therapy) for people with painful or worsening leg artery disease. It uses both past (retrospective) and future (prospective) patient information to better understand outcomes.
This post-market study follows people with significant below-the-knee artery blockages to see how a treatment performs over time. It may help patients by confirming the safety and ongoing effectiveness of the device used for these leg artery problems.
This trial tests an experimental drug for people with critical limb ischemia, a serious condition where not enough blood reaches the legs. It aims to see if the drug can help with pain or healing of leg ulcers without the need for surgery.
This study tests if adding gene therapy to a standard leg artery-opening procedure (angioplasty or stenting) helps people with severe leg pain or non-healing wounds due to blocked arteries. It may improve blood flow and save the leg from amputation.
This trial tests whether stem cells from umbilical cord arteries can help people with severe leg pain or ulcers due to blocked arteries. It is for those who cannot have surgery or other procedures.
Hear when a new Peripheral Arterial Disease(PAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.